Science Explorer Back to mapMap
Discussion
Researcher · Eli Lilly (Germany) · Germany

Monika Iris Leschinger

Monika Iris Leschinger publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.

OpenAlex
World rank
#3,367,283
of 7,710,434 ranked researchers
Rank in Germany
#168,036
of 364,343
Works
24
Citations
605
Citations per work
25.2
h-index
11
i10-index 11Top 46% in Pulmonary and Respiratory Medicine
Monika Iris Leschinger

What does Monika Iris Leschinger research?

Monika Iris Leschinger's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (3%).

Health Sciences: 20 works · 82.4% of their workMedicine: 20 works · 82.4% of their workPulmonary and Respiratory Medicine: 12 works · 51.5% of their workOncology: 5 works · 22.1% of their workCardiology and Cardiovascular Medicine: 1 works · 4.4% of their workSurgery: 1 works · 2.9% of their workEndocrinology, Diabetes and Metabolism: 0 works · 1.5% of their workEverything else: 4 works · 14.7% of their workLife Sciences: 1 works · 2.9% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 2.9% of their workMolecular Biology: 1 works · 2.9% of their workTHEIR WORKMonika IrisLeschinger24works
Life Sciences3%Health Sciences82%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2082.4%
  2. Everything else414.7%
    1. Biochemistry, Genetics and Molecular Biology12.9%
  1. 1Pulmonary and Respiratory Medicine52% of their works
  2. 2Oncology22% of their works
  3. 3Cardiology and Cardiovascular Medicine4% of their works
  4. 4Surgery3% of their works
  5. 5Molecular Biology3% of their works
  6. 6Endocrinology, Diabetes and Metabolism2% of their works

Research topics

Which keywords describe Monika Iris Leschinger's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, CT Screening, Lung Cancer and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Clinical Trials272 topics
  2. Targeted Therapy272 topics
  3. Chemotherapy234 topics
  4. ALK Inhibitors181 topic
  5. EGFR Mutations181 topic
  6. CT Screening101 topic
  7. Lung Cancer101 topic
  8. Genomic Profiles91 topic
  9. Small-Cell Lung Cancer91 topic
  10. Chemotherapy-Induced Peripheral Neuropathy31 topic
  11. Fibrosis31 topic
  12. Idiopathic Pulmonary Fibrosis31 topic
  13. Taxanes31 topic
  14. Blood Pressure21 topic
  15. Cetuximab21 topic
  16. DNA21 topic
  17. Hypertension21 topic
  18. KRAS Mutations21 topic
  19. Topoisomerases21 topic

Where does Monika Iris Leschinger work?

Monika Iris Leschinger's main affiliation in the publication record is Eli Lilly (Germany), Germany.

How many publications and citations does Monika Iris Leschinger have?

OpenAlex counts 24 works and 605 citations for Monika Iris Leschinger, an h-index of 11, ranking #3,367,283 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Monika Iris Leschinger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.